Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
Frampas E, Maurel C, Remaud-Le Saëc P, Mauxion T, Faivre-Chauvet A, Davodeau F, Goldenberg DM, Bardiès M, Barbet J. Frampas E, et al. Among authors: davodeau f. Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2153-64. doi: 10.1007/s00259-011-1903-0. Epub 2011 Aug 20. Eur J Nucl Med Mol Imaging. 2011. PMID: 21858527
Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O, Supiot S, Degraef-Mougin M, Faivre-Chauvet A, Carlier T, Chatal JF, Davodeau F, Cherel M. Couturier O, et al. Among authors: davodeau f. Eur J Nucl Med Mol Imaging. 2005 May;32(5):601-14. doi: 10.1007/s00259-005-1803-2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15841373 Review.
Radiolabeled antibodies for cancer imaging and therapy.
Barbet J, Bardiès M, Bourgeois M, Chatal JF, Chérel M, Davodeau F, Faivre-Chauvet A, Gestin JF, Kraeber-Bodéré F. Barbet J, et al. Among authors: davodeau f. Methods Mol Biol. 2012;907:681-97. doi: 10.1007/978-1-61779-974-7_38. Methods Mol Biol. 2012. PMID: 22907380 Review.
Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. Kraeber-Bodéré F, et al. Among authors: davodeau f. Semin Oncol. 2014 Oct;41(5):613-22. doi: 10.1053/j.seminoncol.2014.07.004. Epub 2014 Jul 22. Semin Oncol. 2014. PMID: 25440606 Review.
Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.
Ménager J, Gorin JB, Maurel C, Drujont L, Gouard S, Louvet C, Chérel M, Faivre-Chauvet A, Morgenstern A, Bruchertseifer F, Davodeau F, Gaschet J, Guilloux Y. Ménager J, et al. Among authors: davodeau f. PLoS One. 2015 Jun 22;10(6):e0130249. doi: 10.1371/journal.pone.0130249. eCollection 2015. PLoS One. 2015. PMID: 26098691 Free PMC article.
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model.
Fichou N, Gouard S, Maurel C, Barbet J, Ferrer L, Morgenstern A, Bruchertseifer F, Faivre-Chauvet A, Bigot-Corbel E, Davodeau F, Gaschet J, Chérel M. Fichou N, et al. Among authors: davodeau f. Front Med (Lausanne). 2015 Nov 4;2:76. doi: 10.3389/fmed.2015.00076. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26582128 Free PMC article.
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
Rousseau C, Ruellan AL, Bernardeau K, Kraeber-Bodéré F, Gouard S, Loussouarn D, Saï-Maurel C, Faivre-Chauvet A, Wijdenes J, Barbet J, Gaschet J, Chérel M, Davodeau F. Rousseau C, et al. Among authors: davodeau f. EJNMMI Res. 2011 Sep 1;1(1):20. doi: 10.1186/2191-219X-1-20. EJNMMI Res. 2011. PMID: 22214534 Free PMC article.
62 results